Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The study evaluates the prostate-specific antigen (PSA) response in HLA-A\*02 positive patients with biochemical recurrence after radical prostatectomy treated with a prostate-specific peptide vaccine in combination with different immune-adjuvants.
Epistemonikos ID: 21d8b83d92c2d2758603e16b54a8f9b464985a5d
First added on: May 12, 2024